Chiral Technology 2018 - Global Strategic Business Report 2015-2022 - Demand for Chiral-based Therapeutic Drugs Augments Growth - ResearchAndMarkets.com

DUBLIN--()--The "Chiral Technology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide market in US$ Thousand by the following Products, and End Use markets:

  • Products - Intermediates, Analytical, and Others
  • End Use markets - Pharmaceuticals, and Agrochemicals

The report profiles 31 companies including many key and niche players such as:

  • Agilent Technologies, Inc. (USA)
  • Albemarle Corporation (USA)
  • BASF SE (Germany)
  • Cambrex Corporation (USA)
  • Chiral Quest (Suzhou) Co., Ltd. (China)
  • Daicel Corporation (Japan)
  • Chiral Technologies, Inc. (USA)
  • Johnson Matthey Fine Chemicals (UK)
  • Phenomenex, Inc. (USA)
  • Regis Technologies, Inc. (USA)
  • Shimadzu Corporation (Japan)
  • Sigma Aldrich Corp. (USA)
  • Solvias AG (Switzerland)
  • Sterling Pharma Solutions Ltd. (UK)
  • Thermo Fisher Scientific, Inc. (USA)
  • YMC America, Inc. (USA)

Key Topics Covered

1. Industry Overview

Good Tidings for Chiral Technology

Developed Markets: Traditional Revenue Contributors

Developing Countries Turbo Charge Future Market Growth

Chiral Intermediates Garner a Larger Pie

Pharmaceuticals: The Largest End-Use Application Domain

Stable Economic Scenario Lends Momentum for Market Growth

American Enterprises Dominate the Market

European Entities Vie to Extend their Share

Asian Players Seek Global Audience

Select M&A Deals Involving Chiral Technology Vendors Finalized in the Recent Past

2. Market Trends, Drivers & Issues

Chiral Technology Plays Pivotal Role in the Pharmaceutical Industry

Demand for Chiral-based Therapeutic Drugs Augments Growth

New Legislations Push Chiral Technology Demand

Single Enantiomer Drugs Gain Prominence

Increasing Reliance on Generic Approaches

Organizations Extend Approaches

Pharma Companies' Association with Universities

Uptrend in Healthcare Expenditure Underpins Present & Future Growth

Chiral Separation Registers Impressive Growth

Soaring Demand for Chiral Separation Columns

3. Technological Advancements

Researchers Explore Methods to Achieve Large-Scale Synthesis of Single-Structure SWCNTs

CHAIN Biotechnology Concludes Ambitious Research Project

Researchers Add Chiral Organocatalyst to Activate C-C Single Bond

Researchers Focus on New Technique for Chiral Separation

Chiral Phosphines to Aid Synthesis of Asymmetric Reactions

Role of Molecular Propeller Effect in Chiral Separation

Analysis

Researchers Develop HPLC Technique for Direct Enantioseparation of -Blockers

4. Chiral Technology - An Overview

5. Chiral Technology - Development Vis-A-Vis Acquisition

6. Chiral Analysis

7. Application Markets

8. Chiral Isomerism

9. Regulatory & Environmental Issues - A Review

10. Product Introductions/Innovations

11. Recent Industry Activity

12. Focus on Select Players

13. Global Market Perspective

Total Companies Profiled: 31 (including Divisions/Subsidiaries - 34)

The United States (18)

Japan (3)

Europe (8)

  • France (1)
  • Germany (2)
  • The United Kingdom (2)
  • Rest of Europe (3)

Asia-Pacific (Excluding Japan) (5)

For more information about this report visit https://www.researchandmarkets.com/research/c43qxz/chiral_technology?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Manufacturing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Manufacturing